20257 results for «»
20257 results
How does the female heart respond to severe aortic stenosis and aortic intervention?
15 May 2024 – From EuroPCR 2024
In this session, gain insights into the gender-specific differences among patients with aortic stenosis (AS) and their implications for treatment strategies. Explore the significance of hemodynamics and durability from a patient's perspective, shedding light on the importance of personalized care. Engage in discussions about the optimal...
The complexity in treatment of patients in shock
16 May 2024 – From EuroPCR 2024
This session is essential for those looking to analyze and discuss the findings of the DanGer shock randomized trial, explore the latest evidence in the ACS field such as Horizon, and implement evidence-based practices in peri-procedural planning, execution, drug administration, and weaning strategies to optimize outcomes...
Mechanical circulatory support in cardiogenic shock: where are we now?
14 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where...
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
Antiplatelet de-escalation after complex PCI: when and how?
14 May 2024 – From EuroPCR 2024
It is now understood that ischemia is not the only risk to consider, as bleeding also plays a significant role. This is why de-escalation is now recommended for patients with complex PCI, as all de-escalation strategies reduce bleeding risk. Discover more about the three different de-escalation...
Mastering the future of PCI with drug-coated balloons
16 May 2024 – From EuroPCR 2024
Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...
Three tailored devices to ease the complex PCI procedures
14 May 2024 – From EuroPCR 2024
At EuroPCR 2024, a round table featuring Jianfang Luo, Benjamin Faurie, and Sevket Gorgulu addresses the challenge of streamlining complex PCI procedures. The discussion focuses on three innovative devices: Expressman™, a guiding extension catheter renowned for its one-piece design and side holes, ensuring adequate antegrade blood...
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES?
14 May 2024 – From EuroPCR 2024
Follow this exchange between Antonio Colombo, Stefan Verheye, and Davide Capodanno as they discuss the past, present, and future of drug-eluting stents. They address the current limitations, emphasizing the issue of vessel caging, and suggest improvements, particularly highlighting the new Bioadaptor with uncaging bioresorbable elements that...
Mental health in the cathlab: is everything really ok?
14 May 2024 – From EuroPCR 2024
Watch Alison Dahlmann and Kristin Rykkje-Johannessen discuss the impact of working in a cathlab on mental health. Despite limited clinical evidence, a two-month online survey revealed that 93% of cathlab workers, across all healthcare professional categories, find the environment stressful, with over 92% experiencing stress and...
Ahead of the curve - Innovate your treatment strategies for optimised clinical outcomes
14 May 2024 – From EuroPCR 2024
Watch this session to learn how to accurately interpret OCT-visualized dissections for an optimized PCI approach using drug-coated balloons (DCB) or drug-eluting stent (DES), to understand the critical role of sufficient and persistent sirolimus content in the vessel wall after using a sirolimus-coated balloon, to get...
AID-ANGIO study: performing ad hoc microvascular assessment during diagnostic coronary angiography
14 May 2024 – From EuroPCR 2024
Christopher Cook interviews Javier Escaned to unravel the AID-ANGIO study, probing its purpose, methodology, and key outcomes. This study aimed to showcase the viability, safety, and diagnostic benefits of performing invasive functional testing ad hoc in managing patients with chronic coronary syndromes.
This interview was filmed at...
Innovations in cardiovascular interventions for chronic heart failure: where are we in 2024?
15 May 2024 – From EuroPCR 2024
Is there an ongoing need for interventions in chronic heart failure? At ACC, a significant trial unveiled interatrial shunting. What does this mean for patients? Explore the devices involved in neuromodulation and considerations for patient discussions. Who might benefit from intravascular monitoring? Watch Giuseppe Rosano and...
How should we manage calcific coronary disease according to the European Consensus document?
15 May 2024 – From EuroPCR 2024
Follow this exchange between James Spratt and Flavio Ribichini for insights into how the European Consensus document offers practical guidance for approaching calcified lesions, the significance of angiography findings, the critical role of intravascular imaging (IVUS or OCT), and device selection based on lesion type. Training...
A new horizon in IVUS-guided PCI of calcified stenoses with artificial intelligence
15 May 2024 – From EuroPCR 2024
In this session, observe the enhanced user-friendliness of IVUS-guided complex PCI with improved AI algorithms, recognize the importance of combining experience with advanced knowledge of tools and techniques for optimal PCI outcomes in heavily calcified stenoses, and understand how tailoring drug-eluting devices for calcified lesions can...
Strengthening cardiovascular care resilience for healthier hearts: the RESIL-Card project
15 May 2024 – From EuroPCR 2024
In this interview at EuroPCR 2024, William Wijns, Niek Klazinga, and Christopher Cook discuss the RESIL-Card initiative, which emerged from the disruption to cardiovascular care during COVID-19. The initiative aims to use this experience to develop a readiness test for future crises. Extensive data has been collected,...
PCR Teaching Assessment Board: innovation in medical education via peer review feedback
15 May 2024 – From EuroPCR 2024
Victoria Jenkins, William Wijns, and Christopher Cook introduce the Teaching Assessment Board, similar to the peer review process in scientific literature. This group provides structured feedback to teachers and participants, inspired by manuscript evaluation methods to enhance educational quality. The aim is to help faculty improve...
What is the optimal management of patients with coronary artery disease and left ventricle dysfunction in 2024?
15 May 2024 – From EuroPCR 2024
Check out this EuroPCR 2024 interview between Valeria Paradies and Vasileios Panoulas to learn about CAD patients with LV dysfunction. Gain insights from the REVIVED trial, which shows that very stable, asymptomatic patients can be treated with medical therapy, including the four pillars of heart failure...
Drug-coated balloon PCI for de novo lesions: when and how?
15 May 2024 – From EuroPCR 2024
Michael Haude and Michael Lee discuss various aspects of DCB PCI, emphasizing lesion preparation, dissection management, and the role of imaging and physiology. They touch upon ongoing studies comparing DCB PCI with DES PCI, consider the duration of DAPT in ACS and non-ACS cases, and explore...
Rapid learning curve to TTVR with the Cardiovalve device
15 May 2024 – From EuroPCR 2024
Explore the discussion between Rodrigo Estevez Loureiro and Georg Nickenig on treating tricuspid regurgitation with the innovative Cardiovalve replacement therapy. Learn about the unique features and properties of this low-profile valve with a dual frame, and hear Estevez Loureiro share his firsthand experience using the TTVR...
The LANDMARK trial: early outcomes of a randomised non-inferiority trial comparing TAVI devices
15 May 2024 – From EuroPCR 2024
In this video, Christopher Cook interviews Patrick Serruys about the late-breaking clinical trial data from the LANDMARK RCT. Patrick Serruys begins by explaining the LANDMARK trial, which compares TAVI devices, and emphasizes the complexity of applying VARC-3 criteria. He highlights that the 30-day outcomes confirm the...
